V2受体拮抗剂托伐普坦对抗人癌症细胞的增殖和侵袭

{"title":"V2受体拮抗剂托伐普坦对抗人癌症细胞的增殖和侵袭","authors":"G. Marroncini, C. Anceschi, L. Naldi, B. Fibbi, F. Baldanzi, M. Maggi, A. Peri","doi":"10.1007/s40618-022-01807-5","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":15651,"journal":{"name":"Journal of Endocrinological Investigation","volume":"45 1","pages":"1693 - 1708"},"PeriodicalIF":3.9000,"publicationDate":"2022-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The V2 receptor antagonist tolvaptan counteracts proliferation and invasivity in human cancer cells\",\"authors\":\"G. Marroncini, C. Anceschi, L. Naldi, B. Fibbi, F. Baldanzi, M. Maggi, A. Peri\",\"doi\":\"10.1007/s40618-022-01807-5\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":15651,\"journal\":{\"name\":\"Journal of Endocrinological Investigation\",\"volume\":\"45 1\",\"pages\":\"1693 - 1708\"},\"PeriodicalIF\":3.9000,\"publicationDate\":\"2022-05-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Endocrinological Investigation\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s40618-022-01807-5\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Endocrinological Investigation","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s40618-022-01807-5","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}